Irritable Bowel Syndrome News

The American College of Gastroenterology developed clinical guidelines for the treatment of irritable bowel syndrome.

Parallel, a prescription digital therapeutic developed by Mahana Therapeutics for the treatment of irritable bowel syndrome, received marketing authorization from the FDA, according to a company press release.

In a year of unprecedented health and social challenges, the American College of Gastroenterology president saw the good that will come from professional medical societies leading the change.

Two peeled kiwi fruit per day improved chronic constipation while being better tolerated than other traditional natural remedies, according to a randomized study presented at ACG 2020 Virtual.

Congratulations to all our winners!

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony on Monday, October 26.

In a composite of three trials, rifaximin provided a durable and significant improvement in bloating in patients with diarrhea-predominant irritable bowel syndrome as compared with placebo, according to results presented at UEG Week.

Allergy-related diseases, including asthma and food hypersensitivity, in childhood were associated with an increased risk of having irritable bowel syndrome at age 16 years, according to research presented at UEG Week Virtual.

Recently, the small intestine bacterial overgrowth breath test was launched by Cedars-Sinai to diagnose small intestine bacterial overgrowth related to irritable bowel syndrome.

Some complimentary alternative therapies, including herbal and dietary supplements, may help ease abdominal pain and benefit overall response in patients with irritable bowel syndrome, according to study results.